Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups

Together with inactivated influenza vaccines (IIV), live attenuated influenza vaccines (LAIV) are an important tool to prevent influenza A virus (IAV) illnesses in patients. LAIVs present the advantages to have a needle-free administration and to trigger a mucosal immune response. LAIV is approved f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonifacio, João P. P. L., Williams, Nathalia, Garnier, Laure, Hugues, Stephanie, Schmolke, Mirco, Mazel-Sanchez, Beryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599596/
https://www.ncbi.nlm.nih.gov/pubmed/36190240
http://dx.doi.org/10.1128/jvi.00871-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599596/
https://www.ncbi.nlm.nih.gov/pubmed/36190240
http://dx.doi.org/10.1128/jvi.00871-22

Ejemplares similares